Skip to menu Skip to content Skip to footer

2024

Other Outputs

MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)

2024

Journal Article

Health system interventions for the cost containment of drugs used for cardiovascular diseases: A systematic review and exploration of how the results could be adapted to the Sri Lankan context

Chaminda, Jayasekara Liyana Patabendige, Kularatna, Sanjeewa, Dharmagunawardene, Dilantha, Hinchcliff, Reece, Rohde, Alexia, Brain, David, Hettiarachchi, Ruvini Manjula, Weerasuriya, Sucharitha Rangi, Yapa, Sunil Senarath and Senanayake, Sameera (2024). Health system interventions for the cost containment of drugs used for cardiovascular diseases: A systematic review and exploration of how the results could be adapted to the Sri Lankan context. Global Health Journal, 8 (4), 181-189. doi: 10.1016/j.glohj.2024.11.005

Health system interventions for the cost containment of drugs used for cardiovascular diseases: A systematic review and exploration of how the results could be adapted to the Sri Lankan context

2024

Other Outputs

MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia

Hettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia

2024

Other Outputs

MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia.

MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation

2024

Journal Article

Impact of removable partial dentures on masticatory performance in partial edentulism: a systematic review

Yaparathna, Navodika, Hettiarachchi, Ruvini Manjula, Love, Robert, Robb, Nigel D. and Abuzar, Menaka (2024). Impact of removable partial dentures on masticatory performance in partial edentulism: a systematic review. International Journal of Prosthodontics, 37 (3), 327-338. doi: 10.11607/ijp.8278

Impact of removable partial dentures on masticatory performance in partial edentulism: a systematic review

2024

Other Outputs

MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation

Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia.

MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation

2024

Journal Article

Cancer survivor preferences for breast cancer follow-up care: a discrete choice experiment

Senanayake, Sameera, Kularatna, Sanjeewa, Crawford-Williams, Fiona, Brain, David, Allen, Michelle, Hettiarachchi, Ruvini M., Hart, Nicolas H., Koczwara, Bogda, Ee, Carolyn and Chan, Raymond J. (2024). Cancer survivor preferences for breast cancer follow-up care: a discrete choice experiment. Journal of Cancer Survivorship. doi: 10.1007/s11764-024-01629-9

Cancer survivor preferences for breast cancer follow-up care: a discrete choice experiment

2023

Other Outputs

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

2023

Journal Article

Comparison of the Early Childhood Oral Health Impact Scale (ECOHIS‐4D) and Child Health Utility Index (CHU‐9D) in children with oral diseases

Weerasuriya, Sucharitha R., Hettiarachchi, Ruvini M., Kularatna, Sanjeewa, Rohde, Alexia, Arrow, Peter, Jamieson, Lisa, Tonmukayakul, Utsana and Senanayake, Sameera (2023). Comparison of the Early Childhood Oral Health Impact Scale (ECOHIS‐4D) and Child Health Utility Index (CHU‐9D) in children with oral diseases. Community Dentistry and Oral Epidemiology, 52 (2), 224-231. doi: 10.1111/cdoe.12917

Comparison of the Early Childhood Oral Health Impact Scale (ECOHIS‐4D) and Child Health Utility Index (CHU‐9D) in children with oral diseases

2023

Conference Publication

Heart Health Hub virtual care pilot program for heart failure patients, Queensland, Australia; A cost consequence study

Hettiarachchi, Ruvini, McClurg, Alicia, Wallis, Shannon, Neill, Johanne, Tomlinson, Rebecca and Carter, Hannah E. (2023). Heart Health Hub virtual care pilot program for heart failure patients, Queensland, Australia; A cost consequence study. 44th Annual AHES Conference, Adelaide, SA, Australia, 21-22 September 2023.

Heart Health Hub virtual care pilot program for heart failure patients, Queensland, Australia; A cost consequence study

2023

Journal Article

Valuing the Dental Caries Utility Index in Australia

Hettiarachchi, Ruvini M., Kularatna, Sanjeewa, Byrnes, Joshua, Mulhern, Brendan, Chen, Gang and Scuffham, Paul A. (2023). Valuing the Dental Caries Utility Index in Australia. Medical Decision Making, 43 (7-8) 0272989X231197149, 901-913. doi: 10.1177/0272989x231197149

Valuing the Dental Caries Utility Index in Australia

2023

Journal Article

A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels

Allen, Michelle J, Doran, Rachael, Brain, David, Powell, Elizabeth E, O’Beirne, James, Valery, Patricia C, Barnett, Adrian, Hettiarachchi, Ruvini, Hickman, Ingrid J and Kularatna, Sanjeewa (2023). A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research, 23 (1) 950, 1-12. doi: 10.1186/s12913-023-09934-2

A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels

2023

Other Outputs

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

2023

Other Outputs

(August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

2023

Other Outputs

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.

2023

Journal Article

Cancer survivor preferences for models of breast cancer follow-up care: selecting attributes for inclusion in a discrete choice experiment

Kularatna, Sanjeewa, Allen, Michelle, Hettiarachchi, Ruvini M., Crawford-Williams, Fiona, Senanayake, Sameera, Brain, David, Hart, Nicolas H., Koczwara, Bogda, Ee, Carolyn and Chan, Raymond J. (2023). Cancer survivor preferences for models of breast cancer follow-up care: selecting attributes for inclusion in a discrete choice experiment. Patient, 16 (4), 371-383. doi: 10.1007/s40271-023-00631-0

Cancer survivor preferences for models of breast cancer follow-up care: selecting attributes for inclusion in a discrete choice experiment

2023

Journal Article

Developing an Australian utility value set for MacNew-7D health states

Kularatna, Sanjeewa, Chen, Gang, Norman, Richard, Mukuria, Clara, Rowen, Donna, Senanayake, Sameera, Hettiarachchi, Ruvini, Mulhern, Brendan, Fozzard, Katie, Parsonage, William and MacPhail, Steven M. (2023). Developing an Australian utility value set for MacNew-7D health states. Quality of Life Research, 32 (4), 1151-1163. doi: 10.1007/s11136-022-03325-6

Developing an Australian utility value set for MacNew-7D health states

2023

Other Outputs

(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

Hettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.

2022

Journal Article

Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment

Hettiarachchi, Ruvini M., Arrow, Peter, Senanayake, Sameera, Carter, Hannah, Brain, David, Norman, Richard, Tonmukayawul, Utsana, Jamieson, Lisa and Kularatna, Sanjeewa (2022). Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. European Journal of Health Economics, 24 (8), 1-12. doi: 10.1007/s10198-022-01542-x

Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment

2022

Other Outputs

‘Surgical Ambassador’ Occupational Violence Prevention Program; Economic Evaluation and eliciting health care staff preferences for Occupational Violence Prevention Program

Duff, Jed, Kularatna, Sanjeewa, Brain, David,, Tyack, Zephanie, Senanayake, Sameera Jayan, Hettiarachchi, Ruvini, Olsson, Lita and Griffiths, Jo (2022). ‘Surgical Ambassador’ Occupational Violence Prevention Program; Economic Evaluation and eliciting health care staff preferences for Occupational Violence Prevention Program. Brisbane, QLD, Australia: Queensland University of Technology. doi: 10.5204/rep.eprints.248024

‘Surgical Ambassador’ Occupational Violence Prevention Program; Economic Evaluation and eliciting health care staff preferences for Occupational Violence Prevention Program